Trials / Sponsors / Isarna Therapeutics GmbH
Isarna Therapeutics GmbH
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabe Primary Open Angle Glaucoma | Phase 1 | 2015-04-01 |
| Terminated | Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary G Anaplastic Astrocytoma, Glioblastoma | Phase 3 | 2008-12-01 |
| Completed | Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce T Pancreatic Neoplasms, Melanoma, Colorectal Neoplasms | Phase 1 | 2005-01-01 |
| Completed | Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma Glioblastoma, Anaplastic Astrocytoma | Phase 2 | 2003-04-01 |